Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

29.90
Delayed Data
As of 4:02pm ET
 +0.46 / +1.56%
Today’s Change
24.47
Today|||52-Week Range
41.91
-8.95%
Year-to-Date
3 Cheap Growth Stocks You Can Buy Right Now
12:12pm / MotleyFool.com - Paid Partner Content
Emergent Down on '17 View, Posts Preliminary '16 Results
Jan 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close29.44
Today’s open29.63
Day’s range29.15 - 30.27
Volume367,736
Average volume (3 months)508,569
Market cap$1.2B
Dividend yield--
Data as of 4:02pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)+60.23%
Earnings growth (this year)-51.06%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+16.14%
P/E ratio30.5
Price/Sales3.62
Price/Book1.76

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-1.15-3.57%
SUPNSupernus Pharmaceuti...+1.25+5.33%
AXONAxovant Sciences Ltd-0.28-2.24%
INVAInnoviva Inc+0.07+0.67%
Data as of 4:01pm ET, 01/23/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)$0.39
Annual revenue (last year)$522.8M
Annual profit (last year)$62.9M
Net profit margin12.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
EVP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts


Search for Jobs